MS Therapeutics Limited
Records under this name other than patents MS Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to MS Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,197,794 | Core 2GLCNAC-T Inhibitors Lapsed on the fee record Ended Jun 12, 2020 · Medium confidence | Lapsed on the fee record | Ended Jun 12, 2020 | Medium confidence |
| US 7,998,943 | Core 2 Glcnac-T Inhibitors III Lapsed on the fee record Ended Aug 16, 2019 · Medium confidence | Lapsed on the fee record | Ended Aug 16, 2019 | Medium confidence |
| US 7,906,493 | Core 2 Glcnac-T Inhibitors Lapsed on the fee record Ended Mar 15, 2019 · High confidence | Lapsed on the fee record | Ended Mar 15, 2019 | High confidence |
| US 7,811,781 | Core 2 BETA(1,6)-ACETYLGLYCOSAMINYLTRANSFERASE as Diagnostic Marker for Atherosclerosis Lapsed on the fee record Ended Oct 12, 2018 · High confidence | Lapsed on the fee record | Ended Oct 12, 2018 | High confidence |
| US 8,609,633 | Core 2 Glcnac-T Inhibitors Lapsed on the fee record Ended Dec 17, 2017 · Low confidence | Lapsed on the fee record | Ended Dec 17, 2017 | Low confidence |